Biopeak has raised $2.7 million in a follow-on funding round led by NKSquared, the investment vehicle of Zerodha cofounder Nikhil Kamath. This is Kamath’s second investment in the company after he deployed $1.43 million into the health optimisation startup in August 2024.
The proceeds will be utilized to expand its operations, including the new clinic and enhancements to its diagnostics, proprietary artificial intelligence (AI) tools, research initiatives, and clinical programmes, Biopeak said in a press release.
Co-founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak uses AI-driven molecular diagnostics, imaging, and expert-led programs to optimize healthspan. The startup focuses on longevity that provides a “family health office” approach, offering personalized plans for healthspan expansion.
The platform integrates organic acid profiling microbiome mapping, whole-exome functional genomics, salivary cortisol rhythms, and imaging (MRI, CT, DXA, ECHO). The startup’s in-house clinics provide specialized care based on data-driven, actionable insights on nutrition, sleep, and stress.
The Bengaluru-based startup targets high achievers, executives, and women, relying on programmes mixing advanced diagnostics, specialist teams, wearable data, and AI insights tailored to Indian biology and disease patterns. The model stresses on early risk detection, longitudinal tracking, and interventions to improve performance and resilience.
Over the past year, Biopeak says that it has grown its client base and clinical offerings amid rising demand for structured longevity services. It opened a clinic in Bengaluru last year, and plans to open a second one in the coming month.
